Myeloma Center
January 11, 2023
Denver Broncos Defensive Tackle D.J. Jones Highlights UAMS Myeloma Center in My Cause, My Cleats Campaign
As part of the National Football League’s (NFL) annual My Cause, My Cleats campaign, Denver Broncos defensive tackle D.J. Jones donated a pair of custom cleats to the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute. Since 2016, participating NFL teams and players customize footwear with designs…
June 17, 2022
Myeloma Patient Celebrates Full Remission by Walking Daughter Down the Aisle
Dave Puente of Elk Grove California, the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) last November, recently saw a very personal goal he’d set for himself become a reality. Late last year, during an interview for an article…
March 16, 2022
Study Puts More Than 50 UAMS Faculty Among Top 2% of Influential Researchers
LITTLE ROCK — A study by Stanford University lists over 50 current and retired UAMS faculty among the top 2% of most influential researchers. The study is based on an analysis of Scopus, the largest database of peer-reviewed research literature. To determine the most influential researchers, the study authors used a combination of citation metrics…
February 28, 2022
Danyelle Musselman to Emcee UAMS Winthrop P. Rockefeller Cancer Institute’s ‘Be a Part of the Cure’ Walk on April 30
On April 30, the first lady of Arkansas Razorback Men’s Basketball, Danyelle Musselman, will emcee the UAMS Winthrop P. Rockefeller Cancer Institute’s “Be a Part of the Cure” Walk honoring all Arkansas cancer patients.
January 20, 2022
Winthrop P. Rockefeller Cancer Institute’s Radiation Oncology Center Becomes First and Only Center in Arkansas to Earn APEx Accreditation
The Radiation Oncology Center at the University of Arkansas for Medical Sciences (UAMS) has received the highest national accreditation from the American Society for Radiation Oncology (ASTRO). The center, which is part of the UAMS Winthrop P. Rockefeller Cancer Institute, is the only radiation oncology center in the state to be granted full accreditation by…
January 13, 2022
First Myeloma Center Patient Receives Revolutionary New Therapy, Responds Well
Dave Puente of Elk Grove, California, became the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) Myeloma Center, the only medical facility in Arkansas currently offering the cutting-edge treatment.
November 15, 2021
Pioneering Researcher Returns to UAMS Myeloma Center
John D. Shaughnessy, Jr., Ph.D., has rejoined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) as a principal staff scientist and professor of medicine. “It feels great to be back,” said Shaughnessy, whose research is focused on developing new targeted therapies for multiple myeloma,…
November 10, 2021
UAMS Raises $15 Million Toward NCI Designation
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) announced today that it has raised more than $15 million towards NCI Designation, the halfway point toward its $30 million goal.
September 21, 2021
Be a Part of the Cure Telethon Raises $400,000
The 2nd annual Be a Part of the Cure Telethon to benefit the UAMS Winthrop P. Rockefeller Cancer Institute’s research and treatment programs raised nearly $400,000 despite a second year of pandemic challenges. “Cancer has affected us all, and the Winthrop P. Rockefeller Cancer Institute continues to see patients, provide treatment and take care of…
August 24, 2021
UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8
Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…
Next page